Work

Long-term response to sunitinib treatment in metastatic renal cell carcinoma (mRCC).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.2_suppl.598

Authors: Nizar M. Tannir, Robert A. Figlin, Martin Eric Gore, Dror Michaelson, Robert J. Motzer, Camillo Porta, Brian I. Rini, Caroline J. Hoang, Xun Lin, Bernard Escudier

Institutions: The University of Texas MD Anderson Cancer Center, Cedars-Sinai Medical Center, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, University of Pavia, Cleveland Clinic, Pfizer (United States), Institut Gustave Roussy

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589305281

Cites:

Cited by: 3

Related to: 10